Details

Autor(en) / Beteiligte

• Soriano Castrejón, Angel(Department of Nuclear Medicine)
• García Vicente, Ana María(Department of Nuclear Medicine)
• Cortés Romera, Montserrat(Department of Nuclear Medicine)
• Cano, Julia Vaamonde(Department of Neurology)
• Marina, Sonia Rodado(Department of Nuclear Medicine)
• Poblete García, Victor Manuel(Department of Nuclear Medicine)
• Ruiz Solís, Sebastián(Department of Nuclear Medicine)
• Talavera Rubio, María del Prado(Department of Nuclear Medicine)

Titel

123-I ioflupane (Datscan®) presynaptic nigrostriatal imaging in patients with movement disorders

Ist Teil von

• Brazilian Archives of Biology and Technology, 2005-10, Vol.48 (spe2), p.115-126

Ort / Verlag

Tecpar

Erscheinungsjahr

2005

Link zum Volltext

Quelle

Free E-Journal (出版社公開部分のみ）

Beschreibungen/Notizen

• 123-I Ioflupane (Datscan®) presynaptic imaging has been shown to have a significant utility in the assessment of patients with movement disorders 123-I Ioflupane SPECT is able to distinguish between Parkinsons disease (PD) and other forms of parkinsonism without degeneration of the nigrostriatal pathway, including a common movement disorder such as essential tremor, and to assess disease progression in PD and other neurodegenerative disorders involving the substantia nigra. A imagem pré-sináptica através de 123-I Ioflupane (Datscan®) tem mostrado um papel significante na avaliação de pacientes com distúrbios do movimento. 123-I Ioflupane SPECT é capaz de distinguir entre Mal de Parkinson (MP) e outras formas de parkinsonismo sem degenerações da via nigroestriatal incluindo um distúrbio comum de movimento parecido com o tremor essencial e para medir a evolução da doença no Mal de Parkinson e outros distúrbios neurodegenerativos envolvendo a substantia nigra.